Mereo BioPharma Group PLC ADR (MREO) — Net Asset Quality Index
Mereo BioPharma Group PLC ADR (MREO) has a Net Asset Quality Index of 86.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $53.60 Million minus total liabilities of $7.00 Million yields net assets of $46.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Mereo BioPharma Group PLC ADR asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mereo BioPharma Group PLC ADR Net Asset Quality Index Over Time (2015–2024)
This chart shows how Mereo BioPharma Group PLC ADR's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the index stands at 86.9%, representing net assets of $46.60 Million against total assets of $53.60 Million USD. See working capital to net assets of Mereo BioPharma Group PLC ADR to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Mereo BioPharma Group PLC ADR (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for Mereo BioPharma Group PLC ADR from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see MREO stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 79.8% | $60.97 Million | $76.39 Million | $15.42 Million | ▲ +3.8 pp |
| 2023 | 76.0% | $50.54 Million | $66.50 Million | $15.96 Million | ▲ +9.6 pp |
| 2022 | 66.4% | $51.40 Million | $77.41 Million | $26.01 Million | ▼ -3.2 pp |
| 2021 | 69.6% | $119.01 Million | $170.96 Million | $51.95 Million | ▲ +93.4 pp |
| 2020 | -23.8% | $-20.47 Million | $86.08 Million | $106.55 Million | ▼ -70.3 pp |
| 2019 | 46.6% | $53.33 Million | $114.52 Million | $61.19 Million | ▼ -2.1 pp |
| 2018 | 48.7% | $32.77 Million | $67.28 Million | $34.51 Million | ▼ -16.1 pp |
| 2017 | 64.9% | $62.48 Million | $96.34 Million | $33.85 Million | ▼ -26.5 pp |
| 2016 | 91.3% | $79.26 Million | $86.76 Million | $7.51 Million | ▼ -3.3 pp |
| 2015 | 94.6% | $101.54 Million | $107.30 Million | $5.76 Million | — |